Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma.

Although there was a general increase in the expression of PD-L1 in CD45 − cells, which are predominantly CT-2A cells, the trend did not reach statistical significance ( Fig. 4c ).

also in 111,027 other papers